Skip to search boxSkip to navigationSkip to main content

Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

  • Zeynep Irem Ozay
    ,
  • Yeonjung Jo
    ,
  • Georges Gebrael
    ,
  • Micah Ostrowski
    ,
  • Vinay Mathew Thomas
    ,
  • Haoran Li
*Corresponding author for this work
  • University of Utah
    ,
  • University of Kansas Cancer Center
    ,
  • Foundation Medicine Inc
    ,
  • Case Western Reserve University
    ,
  • Augusta University
    ,
  • Mayo Clinic Rochester, MN
Scholary Output:
Contribution to journal
Article
 Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

This cohort study examines patterns of bone-modifying agent use from 2013 to 2024 among men with metastatic castration-resistant prostate cancer.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Article number

e2620084

Journal (Volume, Issue Number)

JAMA network open (Volume 9, Issue 6)

Publication milestones

  • Published - 06/24/2026

Publication status

Published - 06/24/2026

Publication IDs

  • Scopus: 105043662342
  • PubMed: 42340725
  • ORCID: /0000-0003-0253-1174/work/225568374

Access to documents